IP Library › Granted Patent US 12,577,583
Granted Patent B2
US 12,577,583 · App. 18/611,182 · Granted Mar 17, 2026

DNA sequence modification-based gene drive

Inventors: Bruce A. Hay (Encino, CA); Georg Oberhofer (Pasadena, CA); Tobin William Ivy (Pasadena, CA)
Assignee: California Institute of Technology
C12N15/85C12N9/22C12N15/907C12N2310/20C12N2800/40C12N2800/50C12N2810/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,577,583
App. No.
18/611,182
Granted
Mar 17, 2026
Kind
B2
Abstract

Described herein are embodiments relating to manipulation of populations and sex ratio in populations through DNA sequence modifications.

Claims (30)

1 . A composition comprising two vectors:

a first vector comprising:

a first sequence encoding a first component of a DNA sequence modifying complex, wherein the first component of the DNA sequence modifying complex is a nuclease, wherein the nuclease is Cas9 nuclease;

a second sequence encoding a second component of the DNA sequence modifying complex, wherein the second component of the DNA sequence modifying complex is a guide RNA, wherein the guide RNA enables the Cas9 nuclease to target specific sequences within the essential gene;

a first promoter operably linked to the first sequence encoding the first component of the DNA sequence modifying complex, wherein the first promoter comprises at least one of a germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter; and

a second promoter operably linked to the second sequence encoding the second component of the DNA sequence modifying complex, wherein the second promoter comprises at least one of a germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter;

wherein the DNA sequence modifying complex is configured to induce one or more sequence modifications in an endogenous copy of an essential gene;

a second vector comprising:

a rescue transgene sequence, wherein the rescue transgene is either a recoded copy of the essential gene or is a gene of unrelated sequence, wherein the rescue transgene encodes a protein that is functionally equivalent to a protein encoded by the essential gene; and

a rescue transgene promoter operably linked to the rescue transgene sequence, wherein the rescue transgene promoter comprises at least one of a endogenous promoter for the essential gene, germline promoter, a male specific germline promoter, a female specific germline promoter, a cell-type specific promoter, a tissue-specific promoter, a ubiquitous promoter, a promoter activated at a specific stage of mitosis, a promoter activated at a specific stage of meiosis, a viral promoter or prokaryotic promoter,

wherein the composition comprising two vectors is configured for reversibly modifying a population of organisms.

2 . The composition of claim 1 , wherein the nuclease cleaves and generates one or more double strand breaks in the endogenous copy of the essential gene.

3 . The composition of claim 2 , wherein the one or more double strand breaks are repaired to create an altered sequence of the essential gene.

4 . The composition of claim 1 , wherein the DNA sequence modifying complex does not modify the rescue transgene.

5 . The composition of claim 1 , wherein the composition comprising two vectors further comprises one or more cargo sequences.

6 . The composition of claim 5 , wherein the one or more cargo sequences comprise a one or more foreign gene sequences, or one or more alleles of an endogenous chromosomal or extra-chromosomal gene to which one of the vectors has been linked through nearby, or internal to the gene, insertion on the chromosome or extra-chromosomal element that carries the endogenous allele of interest.

7 . A method of reversibly modifying a population, the method comprising:

obtaining a wild type organism,

positioning the two vectors of claim 1 in the wild type organism

generating an altered organism by inducing one or more sequence modifications in an essential gene by a DNA sequence modifying complex that result in a defect in survival, growth control, fertility, or differentiation in one or more cells in the organism, and rescuing the defect in survival, growth control, fertility, or differentiation by a rescue transgene in the composition comprising two vectors,

introducing the altered organism in an environment wherein an increase in a frequency of the altered organism is desired relative to a frequency of the wild type organism in a population;

replacing the wild type organism with the altered organism in the population in the environment,

thereby obtaining a modified population

reintroducing the wild type organism in an environment wherein an increase in the frequency of the wild type organism is desired relative to the frequency of the altered organism in the modified population;

replacing the altered organism with the wild type organism in the modified population in the environment,

thereby reversibly modifying the population.

8 . The method of claim 7 , wherein the one or more cells comprise somatic cells, germline cells, gametes, or a combination thereof.

9 . The method of claim 7 , wherein the reversible modification of the population occurs at a rapid rate, high frequency, or both.

10 . The method of claim 9 , wherein the rapid rate is defined as replacement of at least 90% of the wild type organism by the altered organism or vice versa in the population after at most 100 generations.

11 . The method of claim 9 , wherein the high frequency is defined as replacement of at least 90% of the wild type organism by the altered organism or vice versa after 100 generations in the population.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2025
From: HAY, BRUCE A.; OBERHOFER, GEORG; IVY, TOBIN WILLIAM
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 072977/0186 →
Continuity (3)
Division 16673823 · Nov 4, 2019
Provisional Application 62755763 · Nov 5, 2018
Related Publication 20240344081A1 · Oct 17, 2024
References Cited (400)
US 4676981A · Silversides et al. · 1987 [cited by applicant]
US 4879112A · Silversides et al. · 1989 [cited by applicant]
US 4946778A · Ladner et al. · 1990 [cited by applicant]
US 4980286A · Morgan et al. · 1990 [cited by applicant]
US 5139941A · Muzyczka et al. · 1992 [cited by applicant]
US 5173414A · Lebkowski et al. · 1992 [cited by applicant]
US 5354678A · Lebkowski et al. · 1994 [cited by applicant]
US 5436146A · Shenk et al. · 1995 [cited by applicant]
US 5474935A · Chatterjee et al. · 1995 [cited by applicant]
US 5478745A · Samulski et al. · 1995 [cited by applicant]
US 5580859A · Felgner et al. · 1996 [cited by applicant]
US 5589377A · Lebkowski et al. · 1996 [cited by applicant]
US 5589466A · Felgner et al. · 1996 [cited by applicant]
US 5593972A · Weiner et al. · 1997 [cited by applicant]
US 5641870A · Rinderknecht et al. · 1997 [cited by applicant]
US 5652224A · Wilson et al. · 1997 [cited by applicant]
US 5753434A · Ryner et al. · 1998 [cited by applicant]
US 5801030A · McVey et al. · 1998 [cited by applicant]
US 6013770A · Reeves et al. · 2000 [cited by applicant]
US 6284733B1 · Meloen et al. · 2001 [cited by applicant]
US 7339031B2 · Baker et al. · 2008 [cited by applicant]
US 7731939B2 · Miller et al. · 2010 [cited by applicant]
US 10570200B2 · Hay et al. · 2020 [cited by applicant]
US 10966414B2 · Hay et al. · 2021 [cited by applicant]
US 11965172B2 · Hay · 2024 [cited by examiner]
US 12157883B2 · Hay · 2024 [cited by examiner]
US 12213468B2 · Hay et al. · 2025 [cited by applicant]
US 20030213005A1 · Alphey et al. · 2003 [cited by applicant]
US 20050032171A1 · Saxena et al. · 2005 [cited by applicant]
US 20070056051A1 · Alphey · 2007 [cited by applicant]
US 20090183269A1 · Alphey · 2009 [cited by applicant]
US 20100186103A1 · Gao et al. · 2010 [cited by applicant]
US 20100233249A1 · Sutovsky et al. · 2010 [cited by applicant]
US 20110113497A1 · Lee · 2011 [cited by applicant]
US 20120266264A1 · Lee · 2012 [cited by applicant]
US 20130298266A1 · Alphey et al. · 2013 [cited by applicant]
US 20140283155A1 · Akbari et al. · 2014 [cited by applicant]
US 20140356384A1 · Hubbell et al. · 2014 [cited by applicant]
US 20150010578A1 · Balazs et al. · 2015 [cited by applicant]
US 20150159175A1 · Frendewey et al. · 2015 [cited by applicant]
US 20150230430A1 · Wilson et al. · 2015 [cited by applicant]
US 20150237838A1 · Hay et al. · 2015 [cited by applicant]
US 20160060358A1 · Hay · 2016 [cited by applicant]
US 20160345556A1 · Hay · 2016 [cited by examiner]
US 20190241879A1 · Esvelt et al. · 2019 [cited by applicant]
US 20240425845A1 · Hay · 2024 [cited by examiner]
JP 63126482A · 1988 [cited by applicant]
JP 2544120B2 · 1996 [cited by applicant]
KR 1020170041640A · 2017 [cited by applicant]
WO 9011092A1 · 1990 [cited by applicant]
WO 9206180A1 · 1992 [cited by applicant]
WO 9220316A2 · 1992 [cited by applicant]
WO 9222635A1 · 1992 [cited by applicant]
WO 9314188A1 · 1993 [cited by applicant]
WO 9320221A1 · 1993 [cited by applicant]
WO 9408598A1 · 1994 [cited by applicant]
WO 9412649A2 · 1994 [cited by applicant]
WO 9965520A1 · 1999 [cited by applicant]
WO 0107083A1 · 2001 [cited by applicant]
WO 2005095458A1 · 2005 [cited by applicant]
WO 2008009960A2 · 2008 [cited by applicant]
WO 2010049777A1 · 2010 [cited by applicant]
WO 2012143401A1 · 2012 [cited by applicant]
WO 2013176722A2 · 2013 [cited by applicant]
WO 2013176772A1 · 2013 [cited by applicant]
WO 2014052693A2 · 2014 [cited by applicant]
WO 2014096428A1 · 2014 [cited by applicant]
WO 2014120975A1 · 2014 [cited by applicant]
WO 2016049230A1 · 2016 [cited by applicant]
WO 2018204722A1 · 2018 [cited by applicant]
Alhakamy, N.A. et al. “Noncovalently associated cell-penetrating peptides for gene delivery applications,” Therapeutic delivery 4: 741-757, Jun. 2013. [cited by applicant]
Aluwe et al. “Effect of surgical castration, immunocastration and chicory-diet on the meat quality and palatability of boars,” Meat Science 94: 402-407, Jul. 2013. [cited by applicant]
Amatayakul-Chantler, S. et al. “Effects on performance and carcass and meat quality attributes following immunocastration with the gonadotropin releasing factor vaccine Bopriva or surgical castration of Bos indicus bull… [cited by applicant]
Amatayakul-Chantler, S. et al. “Immunocastration of Bos indicus x Brown Swiss bulls in feedlot with gonadotropin-releasing hormone vaccine Bopriva provides improved performance and meat quality,” Journal of animal scien… [cited by applicant]
An, G. et al. “In Vitro and in Vivo Studies Evaluating Recombinant Plasmid Pcxn2-mlzumo as a Potential Immunocontraceptive Antigen,” Am J Reprod Immunol 61: 227-235, 2009. [cited by applicant]
Anderson et al., “Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells,” Nature Immunology, vol. 4, pp. 87-91, 2003. [cited by applicant]
Arimura, A. et al. “Production of Antiserum to LH-Releasing Hormone (LH-RH) Associated with Gonadal Atrophy in Rabbits: Development of Radioimmunoassays for LH-RH,” Endocrinology 93: 1092-1103, 1973. [cited by applicant]
Asano, K., et al., M. Masking of phosphatIdylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 200, pp. 459-467, (2004). [cited by applicant]
ASPCA. https://www.as12ca.org/about-us/fag/12et-statistics.as|2x. This document is not available. It is noted that the document appears to have been publicly available prior to Feb. 1, 2013. ASPCA;https://www.as12ca.org… [cited by applicant]
Ausubel et al., eds., Current Protocols in Molecular Biology, John Wiley & Sons, NY, 1998 (in 11 parts). [cited by applicant]
Avella, M.A. et al. “The molecular basis of gamete recognition in mice and humans,” Molecular utei reproduction 19:279-289, Jan. 17, 2013. [cited by applicant]
Balazs et al., “Antibody-based protection against HIV infection by vectored immunoprophylaxis,” Nature, 481:81-84 (2012) and Supplementary Information (Materials and Methods pp. 1-2). [cited by applicant]
Balazs, A.B. et al. “Broad protection against influenza infection by vectored immunoprophylaxis in mice,” Nat Biotechnol 31: 647-652, Jun. 2, 2013. [cited by applicant]
Barfield, J.P. et al. “Fertility control in wildlife: humans as a model,” Contraception 73: 6-22, 2006. [cited by applicant]
Batorek et al., “Meta-analysis of the effect of immunocastration on production performance, reproductive organs and boar taint compounds in pigs” Animal 6(8):1330-1338, 2012. [cited by applicant]
Battisto et al., “Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen,” Nature, vol. 212, pp. 156-157, 1966. [cited by applicant]
Belldegrun et al. “Human Renal Carcinoma Line Transfected With Interleukin-2 and/or Interferon a Gene(s): Implications for Live Cancer Vaccines,” J Natl Cancer Inst 85: 207-216, 1993. [cited by applicant]
Benavides Valades, G. et al. “Non-invasive assessment of the reproductive cycle in free-ranging female African elephants ( [cited by applicant]
Bird, “Single-chain antigen-binding proteins,” Science 242: 423-442, 1988. [cited by applicant]
Biswajit, P., megaTAL-mediate Gene Editing at the CCR5 locus, PhD Dissertation, University of Washington, pp. 1-113, 2016. [cited by applicant]
Bleil, J.D. et al., “Identification of a ZP3-binding protein on acrosome-intact mouse sperm by photoaffinity crosslinking,” Proc Natl Acad Sci USA 87: 5563-5567, 1990. [cited by applicant]
Boesen et al. “Circumvention of chemotherapy-induced myelosuppression by transfer of themdr1 gene,” Biotherapy 6: 291-302, 1993. [cited by applicant]
Bondanza, A., et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. Journal of Experimental Medicine 200, 1157-1165, (2004). [cited by applicant]
Bondanza, A., et al., Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum—Us 50, pp. 1549-1560, (2004). [cited by applicant]
Bonneau et al., “The Effects of Immunization Against Luteinizing Hormone-Releasing Hormone on Performance, Sexual Development, and Levels of Boar Taint-Related Compounds in Intact Male Pigs,” Journal of Animal Science 7… [cited by applicant]
Boue, F. et al. “Cases of Human Infertility are Associated with the Absence of P34H, an Epididymal Sperm Antigen',” Biol Reprod 54: 1018-1024, 1996. [cited by applicant]
Bout et al. “Lung Gene Therapy: In Vivo Adenovirus-Mediated Gene Transfer to Rhesus Monkey Airway Epithelium,” Human Gene Therapy 5: 3-10, 1994. [cited by applicant]
Brevini et al., Theriogeneology, 74: 554-550, 2010. [cited by applicant]
Buchlis, G. et al. “Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer,” Blood 119: 3038-3041, 2012. [cited by applicant]
Burkart, A.D. et al. “Ovastacin, a cortical granule protease, cleaves ZP2 in the zona pellucida to prevent polyspermy” J Cell Biol 197, 37-44, 2012. [cited by applicant]
Burt A, Trivers R Genes in Conflict: The Biology of Selfish Genetic Elements Belknap Press, Cambridge, MA, 1st Ed. pp. 1-602, only p. 43 (Year: 2008). [cited by applicant]
Burtea et al., “Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques,” Molecular pharmaceutics, vol. 6, pp. 1903-1919, 2009. [cited by applicant]
Calcedo, R. et al. “Adeno-associated virus antibody profiles in newborns, children, and adolescents,” Clinical and Vaccine Immunology : CVI 18, 1586-1588, 2011. [cited by applicant]
Calcedo, R. et al. “Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses,” The Journal of Infectious Diseases 199, 381-390, 2009. [cited by applicant]
Caltech: “Long-Term Contraception in a Single Shot,:” https://www.caltech.edu/news/long-term-contraception-single-shot-48199 Oct. 6, 2015. [cited by applicant]
Cao et al., J. of Exp. Zoo., 311A: 368-376, 2009. [cited by applicant]
Carson et al., “Production and biological activity of murine monoclonal antibodies against GnRH,” Theriogenology, vol. 48, No. 2, pp. 193-207, 1997. [cited by applicant]
Chamley, L.W. et al., “Antisperm antibodies and conception,” Seminars in Immunopathology, vol. 29, pp. 169-184, 2007. [cited by applicant]
Chen, S-J., et al. Enhancing the Utility of Adena-Associated Vims Gene Transfer through Inducible Tissue-Specific Expression, Hum Gene Ther Methods. 24: 270-278, Aug. 20, 2013. [cited by applicant]
Chen, Y. et al. “Construction of sperm-specific lactate dehydrogenase DNA vaccine and experimental study of its immuno-contraceptive effect on mice,” Science in China Series C, Life sciences / Chinese Academy of Science… [cited by applicant]
Chien, W.M. et al., “Genomic DNA recombination with cell-penetrating peptide-tagged ere protein in mouse skeletal and cardiac muscle”, Genesis, vol. 52, pp. 695-701, 2014. [cited by applicant]
Chothia et al. “Structural determinants in the sequences of immunoglobulin variable domain,” J Mol Biol 278: 457-479, 1998. [cited by applicant]
Ciciliot, S. et al. “Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications,” Curr Pharm Des 16, 906-914, 2010. [cited by applicant]
Clark et al. Nature Reviews: 4: 825-833, 2003. [cited by applicant]
Clarke, I.J. “Two decades of measuring GnRH secretion,” Reproduction Supplement 59: 1-13, 2002. [cited by applicant]
Clarke, I.J. “Control of GnRH secretion: one step back,” Frontiers in Neuroendocrinology, vol. 32, pp. 367-375, 2011. [cited by applicant]
Clarke, I.J. “Interface between metabolic balance and reproduction in ruminants: focus on the hypothalamus and pituitary,” Hormones and Behavior, vol. 66, pp. 15-40, 2014. [cited by applicant]
Clarke, I.J. et al. “Active immunization of ewes against luteinizing hormone releasing hormone, and its effects on ovulation and gonadotrophin, prolactin and ovarian steroid secretion,” The Journal of endocrinology 78: … [cited by applicant]
Cline “Perspectives for gene therapy: Inserting new genetic information into mammalian cells by physical techniques and viral vectors,” Pharmac Ther 29: 69-92, 1985. [cited by applicant]
Clowes et al. “Long-Term Biological Response of Injured Rat Carotid Artery Seeded with Smooth Muscle Cells Expressing Retrovirally Introduced Human Genes,” J Clin Invest 93: 644-651, 1994. [cited by applicant]
Coffin, J.M., “Retroviridae: The viruses and their replication”, Chapter 26, Fundamental Virology, Third Edition, Edited by Fields, B.N, et al., Lippincott—Raven Publishers, Philadelphia, 1996. [cited by applicant]
Contraceptive Technology, Edited by Robert A. Hatcher, James Trussell and Anita L. Nelson. PDR Network, 19th edition, 2008. [cited by applicant]
Cooper, D.W. et al. “Immunocontraception of mammalian wildlife: ecological and immunogenetic issues,” Reproduction 132: 821-828, 2006. [cited by applicant]
Cotten et al. “Receptor-mediated transport of DNA into eukaryotic cells,” Meth Enzymol 217: 618-644, 1993. [cited by applicant]
Cox, J. et al. “MaxQuant enables high peptide identification rates, individualized p.p.b.—range mass accuracies and proteome-wide protein quantification,” Nat Biotechnol 26, 1367-1372, 2008. [cited by applicant]
Cox, J. et al. “Andromeda: a peptide search engine integrated into the MaxQuant environment,” J Proteome Res 10, 1794-1805, 2011. [cited by applicant]
Crawford, E.D. et al., “Long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix”, Urology, vol. 83, No. 5, pp. 1122-1128, 201… [cited by applicant]
Cremel et al., “Red blood cells as innovative antigen carrier to induce specific immune tolerance,” International journal of pharmaceutics, vol. 443, pp. 39-49, 2013. [cited by applicant]
D'Occhio et al., “Sustained testicular atrophy in bulls actively immunized against GnRH: potential to control carcase characteristics,” Animal Reproduction Science 66: 47-58, 2001. [cited by applicant]
Darroch, J.E. et al. “Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys,” Lancet 381, 1756-1762, May 2013. [cited by applicant]
Das, A., et al. Flippase-mediated phospholipid asymmetry promotes fast Cdc42 recycling in dynamic maintenance of cell polarity. Nat Cell Biol 14, pp. 304-310, (2012). [cited by applicant]
Dasgupta et al., “Role of lactadherin in the clearance of phosphatidylserine-expressing red blood cells,” Transfusion, vol. 48, pp. 2370-2376, 2008. [cited by applicant]
Davies, B. et al. “Targeted Deletion of the Epididymal Receptor HE6 Results in Fluid Dysregulation and Male Infertility,” Mol Cell Biol 24: 8642-8648, 2004. [cited by applicant]
De la Cruz, A. et al. “Effect of Administration of Anti-Serum to Luteinizing Hormone-Releasing Hormone on Gonadal Function During the Estrous Cycle in the Hamster,” Endocrinology 98: 490-497, 1976. [cited by applicant]
De Nys, H.M. et al. “Vaccination against GnRH may suppress aggressive uteiniz and musth in African elephant ( [cited by applicant]
Deehan, M. et al., “Managing unwanted immunogenicity of biologicals”, Autoimmunity Reviews, vol. 14, pp. 569-574,2015. [cited by applicant]
Desjarlais, J.R. et al. “Modulation of antibody effector function,” Exp Cell Res 317: 1278-1285, 2011. [cited by applicant]
Diekman, A.B. et al. “N-linked glycan of a sperm CD52 glycoform associated with human infertility,” FASEB J 13: 1303-1313, 1999. [cited by applicant]
Diekman, A.B. et al. “Evidence for a unique N-linked glycan associated with human infertility on sperm CD52: a candidate contraceptive vaccinogen,” Immunological reviews 171: 203-211, 1999. [cited by applicant]
Dismuke, D.J. et al., “Biosafety of recombinant adeno-associated vims vectors”, Current Gene Therapy, vol. 13, pp. 434-452, Dec. 2013. [cited by applicant]
Dmce, H.C. et al. “How Immunocontraception Can Contribute to Elephant Management in Small, Enclosed Reserves: Munyawana Population as a Case Study,” PloS One 6: e27952, 2011. [cited by applicant]
Dong, Y. et al. “An in vitro approach for production of non-scar minicircle DNA vectors,” Journal of biotechnology 166: 84-87, Jul. 10, 2013. [cited by applicant]
Donovan, C. et al. “Physiologic responses following gonadotropin-releasing hormone immunization in intact male dogs,” Reproduction in Domestic Animals = Zuchthygiene 47 (Suppl 6): 403-405, 2012. [cited by applicant]
Dorman, E. et al. “Demand for male contraception,” Expert Review of Pharmacoeconomics & Outcomes Research 12, 605-613, 2012. [cited by applicant]
Dunshea, F.R. et al. “Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance,” Journal of Animal Science 79: 2524-2535, 2001. [cited by applicant]
East, I.J. et al. “Monoclonal antibodies to the major protein of the murine zona pellucida: Effects on fertilization and early development,” Dev Biol 104: 49-56, 1984. [cited by applicant]
East, I.J. et al. “Monoclonal antibodies to the murine zona pellucida protein with sperm receptor activity: Effects on fertilization and early development,” Dev Biol 109: 268-273, 1985. [cited by applicant]
Elliott, J.I., et al. (2005). Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7, pp. 808-816, (2005). [cited by applicant]
Engelhardt et al. “Adenovims-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study,” Human Genet Ther 4: 759-769, 1993. [cited by applicant]
Eurogentec, “Gonadotrophin-Releasing Hormone (LHRH) (SMI 41) Monoclonal Antibody” from Eurogentec Price List of Covance Antibodies, 2011. [cited by applicant]
Ferrantini et al. “IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell- mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-pr… [cited by applicant]
Ferrantini et al. “a-Interferon Gene Transfer into Metastatic Friend Leukemia Cells Abrogated Tumorigenicity in Immunocompetent Mice: Antitumor Therapy by Means of Interferon-producing Cells,” Cancer Research 53: 1107-1… [cited by applicant]
Ferro, V.A. et al., Reproductive component vaccine developments for contraceptive and noncontraceptive uses, Expert Opin. Ther. Patents, vol. 21, No. 9, 2011. [cited by applicant]
File History of U.S. Appl. No. 14/206,011, filed Mar. 12, 2014. [cited by applicant]
File History of U.S. Appl. No. 14/631,171, filed Feb. 25, 2015. [cited by applicant]
File History of U.S. Appl. No. 15/970,728, filed May 3, 2018. [cited by applicant]
File History of U.S. Appl. No. 14/170,118. [cited by applicant]
Found-animals-foundation. http://www.foundanimals.org/pet-spay-neuter/la-lowcost-free-neuter-spay; Original publication date unknown; Version printed on Mar. 22, 2016. [cited by applicant]
Fraker, M.A. et al. “Long-Lasting, Single-Dose Immunocontraception of Feral Fallow Deer in British Columbia ,” Journal of Wildlife Management 66: 1141-1147, 2002. [cited by applicant]
Fraser, “Antifertility effects of GnRH” J. Reprod. Fert. 64:503-515 (1982). [cited by applicant]
Fraser, H.M. “Effect of active immunization to luteinizing hormone releasing hormone on gonadotrophin levels in ovariectomized rats,” The Journal of endocrinology 64: 191-192, 1975. [cited by applicant]
Fraser, H.M. et al. “Changes in the ovaries of rats after immunization against luteinizing hormone releasing hormone,” The Journal of endocrinology 77: 85-93, 1978. [cited by applicant]
Fraser, H.M. et al. “Gonadotrophin release by a highly active analogue of luteinizing hormone releasing hormone in rats immunized against luteinizing hormone releasing hormone,” The Journal of endocrinology 74: 291-296,… [cited by applicant]
Fraser, H.M. et al. “Effects of Antibodies to Luteinizing Hormone—Releasing Hormone in the Male Rabbit and on the Rat Oestrous Cycle,” Nature 244: 160-161, 1973. [cited by applicant]
Fu, J. et al. “Anti-ACTL7a antibodies: a cause of infertility,” Fertility and sterility 97: 1226-1233, 2012. [cited by applicant]
Gaitonde et al., “Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice,” J. Biol. Chem., vol. 288, pp. 17051-17056, 2013. [cited by applicant]
Gaitonde et al., “Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function,” Clin. Immunol., vol. 138, pp. 135-145, 2011. [cited by applicant]
Gaj, T. et al. “ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering,” Trends Biotechnol. 3 1: 397-405, Jul. 2013. [cited by applicant]
Galli, R.A. et al. “Evaluation of the accuracy and ease of use of a rapid HIV-1 Antibody Test performed by untrained operators at the point of care,” Journal of Clinical Virology 58 Suppl 1, e65-69, Dec. 2013. [cited by applicant]
Galluzzi, et al., Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, J Immunother Cancer, 8:e000337, pp. 1-22, 2020. [cited by applicant]
Geary, T.W. et al.“Use of recombinant gonadotropin-releasing hormone antigens for immunosterilization of beef heifers,” Journal of animal science 84: 343-350, 2006. [cited by applicant]
Getts et al., “Exploiting apoptosis for therapeutic tolerance induction,” J. Immunol., vol. 191, pp. 5341-5346, 2013. [cited by applicant]
Getts et al., “Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells”, J. Immunol., vol. 187, pp. 2405-2417, 2011. [cited by applicant]
Gledhill, B. et al. “Effect of passive immunization against LH-RH on gonadotrophin secretion in the ferret,” J Reprod Fertil 64: 19-23, 1982. [cited by applicant]
Gobello, C. “Effects of GnRH antagonists vs agonists in domestic carnivores, a review,” Reproduction in Domestic Animals 47 Suppl 6, 373-376, 2012. [cited by applicant]
Godfrey, S.I. et al. “Immunisation of goat bucks against GnRH to prevent seasonal reproductive and agonistic uteiniz,” Animal Reprod. Sci. 44: 41-54, 1996. [cited by applicant]
Goldberg, E. “Developmental expression of lactate dehydrogenase isozymes during spermatogenesis,” Progress in clinical and biological research 344: 49-52, 1990. [cited by applicant]
Gomez e tal., Theriogeneology, 74: 498-515, 2010. [cited by applicant]
Gong et al., “Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment,” Molecular Imaging, vol. 12, pp. 244-256, 2013. [cited by applicant]
Goode et al., “Regulatory B cells: the new “it” cell,” Transplantation proceedings, vol. 46, pp. 3-8, 2014. [cited by applicant]
Goodman, R.L. et al. “Kisspeptin neurons from mice to men: similarities and differences,” Endocrinology 153, 5105-5118, 2012. [cited by applicant]
Gracey Maniar, L.E. et al. “Minicircle DNA Vectors Achieve Sustained Expression Reflected by Active Chromatin and Transcriptional Level,” Molecular therapy: the journal of the American Society of Gene Therapy 21:131-138… [cited by applicant]
Graham et al., Genome Biology, 16: 260, 2014. [cited by applicant]
Grandy, J.W. et al. “An animal welfare view of wildlife contraception,” Reprod Suppl 60, 1-7, 2002. [cited by applicant]
Green et al. “Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenovimses,”, Proc Natl Acad Sci USA 76: 6606-6610, 1979. [cited by applicant]
Greenhouse, S. et al. “Antibodies to human ZP3 induce reversible contraception in transgenic mice with ‘humanized’ zonae pellucidae,” Hum Reprod 14: 593-600, 1999. [cited by applicant]
Griffiths, E.C. et al. “Mechanisms of inactivation of hypothalamic regulatory hormones,” Molecular and Cellular Endocrinology 14, 3-17, 1979. [cited by applicant]
Grossman et al. “Retroviruses: delivery vehicle to the liver,” Curr Opin in Genetics and Devel 3: 110-114, 1993. [cited by applicant]
Guillen et al., “Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer,” Pancreas, vol. 44, pp. 945-952, 2015. [cited by applicant]
Gupta et al. “Milestones in contraceptive vaccines development and hurdles in their application,” Human Vaccines and immunotherapeutics 10(4): 911-925, 2014; Epub Nov. 21, 2013. [cited by applicant]
Gupta SK et al. Contraceptive vaccines based on the zone pellucida glycoproteins for dogs and other wildlife population management. Am J Reprod Immunol; 66: 51-62, 2011. [cited by applicant]
Gupta, S.K. et al. “Vaccines for immunological control of fertility,” Reprod Med Biol 9(2): 61-71, 2010. [cited by applicant]
Gupta, S.K. et al. “Zona pellucida-based contraceptive vaccines for human and animal utility,” Journal of reproductive immunology 88: 240-246, 2011. [cited by applicant]
Hanayama et al., “Identification of a factor that links apoptotic cells to phagocytes,” Nature, vol. 417, pp. 182-187, 2002. [cited by applicant]
Hanayama et al., “MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure,” Current directions in autoimmunity, vol. 9, pp. 162-172, 2006. [cited by applicant]
Hanayama, R., et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-ES-deficient mice. Science 304, pp. 1147-1150, (2004). [cited by applicant]
Hao, M. et al. “Expression of a recombinant bifunctional protein from a chimera of human lutropin receptor and human chorionic gonadotropin-subunit,” Journal of reproductive immunology 63: 123-135, 2004. [cited by applicant]
Hardy, C.M. et al. “Biological control of vertebrate pests using virally vectored immunocontraception,” Journal of Reproductive Immunology 71, 102-111, 2006. [cited by applicant]
He et al., “Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells,” EMBO Rep., vol. 12, pp. 358-364, 2011. [cited by applicant]
Hearn , J .P. “Immunization against Pregnancy,” Proc R Soc Lond B Biol Sci 195: 149-160, 1976. [cited by applicant]
Heid and Hamm, “Animal welfare versus food quality: Factors influencing organic consumers' preferences for alternatives to piglet castration without anaesthesia,” Meat Science 95: 203-211, Oct. 2013. [cited by applicant]
Herlyn, H. et al. “The molecular evolution of sperm zonadhesin,” The Internationaljournal of developmental biology 52: 781-790, 2008. [cited by applicant]
Herr, J.C. et al. “Identification of Human Acrosomal Antigen SP-10 in Primates and Pigs,” Biol Reprod 42: 377-382, 1990. [cited by applicant]
Hicks, M.J. et al. “AAV-Directed Persistent Expression of a Gene Encoding Anti-Nicotine Antibody for Smoking Cessation,” Sci Transl Med 4: 140ra87, 2012. [cited by applicant]
Hodges, J.K. et al. “Effects of immunisation against luteinizing hormone releasing hormone on reproduction of the marmoset monkey Callithrixjacchus,” Nature 265: 746-748, 1977. [cited by applicant]
Humane-society. http://www.humanesociety.org/issues/pet_overpopulation/facts/pet_ownership_statistics.html; Original publication date unknown; Version printed on Mar. 22, 2016. [cited by applicant]
Huston et al. “Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in [cited by applicant]
Igarashi et al., “A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine d… [cited by applicant]
Igarashi, K., et al., Specific binding of a synthetic peptide derived from an antibody complementarity determininQ region to phosphatidylserine, Journal of Biochemistry, vol. 117, pp. 452-457, 1995. [cited by applicant]
International Search Report and Written Opinion issued on Apr. 25, 2014, in PCT Application PCT/US2014/013943. [cited by applicant]
Ishimoto et al., “Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gash,” J. Biochem., vol. 127, pp. 411-417, 2000. [cited by applicant]
Isojima, S. et al. “Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma,” Journal of rep… [cited by applicant]
Isojima, S. et al. “Further studies on sperm-immobilizing antibody found in sera of unexplained cases of sterility in women,” Am J Obstet Gynecol 112: 199-207, 1972. [cited by applicant]
Isojima, S. et al. “Immunologic analysis of sperm-immobilizing factor found in sera of women with unexplained sterility,” Am J Obstet Gynecol 101 : 677-683, 1968. [cited by applicant]
Itoh et al., “Staphylococcal superantigen-like protein 10 binds to phosphatidylserine and apoptotic cells,” Microbiology and immunology, vol. 56, pp. 363-371, 2012. [cited by applicant]
Jackson, R.J. et al. “Infertility in mice induced by a recombinant ectromelia vims expressing mouse zona pellucida glycoprotein 3,” Biol Reprod 58, 152-159, 1998. [cited by applicant]
Jagadish, N. et al. “Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9),” Vaccine 24: 3695-3703, 2006. [cited by applicant]
Janett, F. et al. “Effect of vaccination against gonadotropin-releasing factor (GnRF) with Bopriva® in the prepubertal bull calf,” Animal reproduction science 131: 72-80, 2012. [cited by applicant]
Janett, F. et al. “Suppression of testicular function and sexual behavior by vaccination against GnRH (EquityTM) in the adult stallion,” Animal reproduction science 115: 88-102, 2009. [cited by applicant]
Janett. F. et al. “Vaccination against gonadotropin-releasing factor (GnRF) with Bopriva significantly decreases testicular development, serum testosterone levels and physical activity in pubertal bulls,” Theriogenology… [cited by applicant]
Jang, Y.C. et al. “Skeletal Muscle Stem Cells: Effects of Aging and Metabolism on Muscle Regenerative Function,” Cold Spring harb Symp Quant Biol. 76: 101-111, 2011. [cited by applicant]
Jean et al. Develop. Growth Differ., (55): 41-51, 2013. [cited by applicant]
Jeffcoate, I.A. et al. “Effect of active immunisation of ewes against synthetic luteinizing hormone releasing hormone,” Theriogenology 10: 323-335, 1978. [cited by applicant]
Jeffcoate, S.L. et al. “Preparation and specificity of antibodies to the decapeptide, luteinizing hormone-releasing hormone (LH-RH),” Immunochemistry 11: 75-77, 1974. [cited by applicant]
Jefferis et al., “Human immunoglobulin allotypes: possible implications for immunogenicity,” mAbs., vol. 1, pp. 332-338, 2009. [cited by applicant]
Johnson, P.R. et al. “Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys,” Nat Med 15: 901-906, 2009. [cited by applicant]
Jones et al., “Improving the safety of cell therapy products by suicide gene transfer,” Frontiers in pharmacology, vol. 5, Article 524, pp. 1-8, Nov. 27, 2014. [cited by applicant]
Jones et al., “Replacing the complementarity-determining regions in a human antibody with those from a mouse,” Nature 321:522-525, 1986. [cited by applicant]
Kaido, T., et al. “IFN-a1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice,” Int J Cancer 60: 2… [cited by applicant]
Kalli, A. et al. “Evaluation and optimization of mass spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass analyzers,” J Proteome Res 12, 3071-3086, May 5, 2013. [cited by applicant]
Kaminska, A. et al. .Lactadherin: An unappreciated haemostasis regulator and potential therapeutic agent. Vascul Pharmacol 101, pp. 21-28, (2018). [cited by applicant]
Kaneda et al. “Increased expression of DNA cointroduced with nuclear protein in adult rat liver,” Science 243: 375, 1989. [cited by applicant]
Kapty et al., “Evaluation of phosphatidylserine-binding peptides targeting apoptotic cells,” Journal of Biomolecular Screening, vol. 17, pp. 1293-1301, 2012. [cited by applicant]
Kay, “State-of-the-art gene-based therapies: the road ahead,” Nat. Rev. Genet., vol. 12, pp. 316-328, 2011. [cited by applicant]
Kay, M.A. et al. “A robust system for production ofminicircle DNA vectors,” Nat Biotechnol 28: 1287-1289, 2010. [cited by applicant]
Kazama et al., Induction of Immunological Tolerance by Apoptotic Cells Requires Caspase-Dependent Oxidation of High-Mobility Group Box-1 Protein, Immunity, vol. 29, pp. 21-32, 2008. [cited by applicant]
Keene, J.L. et al. “Recombinant deglycosylated human FSH is an antagonist of human FSH action in cultured granulosa cells,” Endocrine Journal 2, 175-180, 1994. [cited by applicant]
Kiem et al. “Retrovirus-Mediated Gene Transduction Into Canine Peripheral Blood Repopulating Cells,” Blood 83: 1467-1473, 1994. [cited by applicant]
Kim et al., “Advantages of the phosphatidylserine-recognizing peptide PSP1 for molecular imaging of tumor apoptosis compared with annexin V,” PLoS One, vol. 10, No. 3, pp. e0121171, 2015. [cited by applicant]
Kim, Y.H. et al. “Compartmentalization of a Unique ADP/ATP Carrier Protein SFEC (Sperm Flagellar Energy Carrier, AAC4) with Glycolytic Enzymes in the Fibrous Sheath of the Human Sperm Flagellar Principal Piece,” Dev Bio… [cited by applicant]
Kirchhoff, C. and Hale, G. “Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation,” Molecular human reproduction 2(3): 177-184, 1996. [cited by applicant]
Kirkpatrick, J.F. et al. “Contraceptive Vaccines for Wildlife: A Review,” Am J Reprod Immunol 66: 40-50, 2011. [cited by applicant]
Kirkpatrick, J.F. et al. “The practical side of immunocontraception: zona proteins and wildlife,” Journal of reproductive immunology 83: 151-157, 2009. [cited by applicant]
Knapp, R.J. et al. “High affinity monoclonal antibodies to luteinizing hormone-releasing hormone. Preparation and binding studies,” J Neuroimmunol 6, 361-371, 1984. [cited by applicant]
Kobayashi et al., “TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells”, Immunity, vol. 27, pp. 927-940, 2007. [cited by applicant]
Koch, Y. et al. “Suppression of gonadotropin secretion and prevention of ovulation in the rat by antiserum to synthetic gonadotropin-releasing hormone,” Biochem Biophys Res Commun 55: 623-629, 1973. [cited by applicant]
Koller et al. “Inactivating the β-microglobulin locus in mouse embryonic stem cells by homologous recombination,” Proc Natl Acad Sci USA 86: 8932-8935, 1989. [cited by applicant]
Komori, S. et al. “Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology,” Clinical and experimental immunology 71: 508-516, 1988. [cited by applicant]
Kontos et al., “Engineering antigens for in situ erythrocyte binding induces T-cell deletion,” Proc. Natl. Acad. Sci. USA., vol. 110, pp. E60-E68, 2013. [cited by applicant]
Kormann, M.S. et al. “Expression of therapeutic proteins after delivery of chemically modified mRNA in mice,” Nat Biotechnol 29, 154-157, 2011. [cited by applicant]
Kozarsky and Wilson “Gene therapy: adenovims vectors,” Current Opinion in Genetics and Development 3: 499-503, 1993. [cited by applicant]
Krause, W.K.H. and Naz, R.K., eds. in Immune Infertility (Berlin, Germany: Springer-Verlag), 2009. [cited by applicant]
Krutskikh, A. et al. “Epididymal protein Rnase10 is required for posttesticular sperm maturation and male fertility,” FASEB J 26: 4198-4209, 2012. [cited by applicant]
Kumar, P. et al. “Gonadotropin-releasing hormone analogs: Understanding advantages and limitations,” Journal of Human Reproductive Sciences 7, 170-174, 2014. [cited by applicant]
Kuriyama et al., “Improvement of peptide vectors for gene delivery with active targeting profiles for phosphatidylserine,” Journal of peptide science: an official publication of the European Peptide Society, vol. 15, pp… [cited by applicant]
Kurosawa, N. et al. “Rapid production of antigen-specific monoclonal antibodies from a variety of animals,” BMC biology 10: 80, 2012. [cited by applicant]
Kurosawa, N. et al. “Target-selective homologous recombination cloning for high-throughput generation of monoclonal antibodies from single plasma cells,” BMC biotechnology 11: 39, 2011. [cited by applicant]
Kutmeier et al. “Assembly of humanized antibody genes from synthetic oligonucleotides using a single-round PCR,” BioTechniques 17: 242, 1994. [cited by applicant]
Kutzler, M. and Wood, A. “Non-surgical methods of contraception and sterilization,” Theriogenology 66: 514-525, 2006. [cited by applicant]
Lack et al., A Thousand Fly Genomes: An Expanded [cited by applicant]
Landsteiner et al., “Studies on the Sensitization of Animals with Simple Chemical Compounds”, J. Exp. Med., vol. 61, pp. 643-656, 1935. [cited by applicant]
Laumonier et al., “A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology,” Journal of biomolecular screening, vol. 11, pp. 537-545, 2006. [cited by applicant]
Lea, I.A. et al. “Autoimmunogenicity of the human sperm protein Spl 7 in vasectomized men and identification oflinear B cell epitopes,” Fertility and sterility 67: 355-361, 1997. [cited by applicant]
Lee et al., “Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver,” Blood, vol. 117, pp. 5215-5223, 2011. [cited by applicant]
Lee, E.C. et al. “Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery,” Nat Biotechnol 32, 356-363, 2014. [cited by applicant]
Lefevre, A. et al. “Characterization and isolation of SOB2, a human sperm protein with a potential role in oocyte membrane binding,” Molecular human reproduction 3: 507-516, 1997. [cited by applicant]
Leone, P. et al. “Long-term follow-up after gene therapy for canavan disease,” Sci Transl Med 4, 165ral63, 2012. [cited by applicant]
Levy, J. K. “Contraceptive Vaccines for the Humane Control of Community Cat Populations,” Am J Reprod Immunol 66: 63-70, 2011. [cited by applicant]
Levy, J.K. et al. “Long-term fertility control in female cats with GonaCon™, a GnRH immunocontraceptive,” Theriogenology 76: 1517-1525, 2011. [cited by applicant]
Li, J. et al. “Vectored antibody gene delivery mediates long-term contraception,” Current Biology 25: R811-R826, 2015. [cited by applicant]
Li, L. et al. “Production and characterization of novel recombinant adeno-associated vims replicative-form genomes: a eukaryotic source of DNA for gene transfer,” PloS One 8: e69879, Aug. 1, 2013a. [cited by applicant]
Li, W. et al. “TexIOI is essential for male fertility by affecting sperm migration into the oviduct in mice,” Journal of molecular cell biology 5:345-347, Aug. 22, 2013. [cited by applicant]
Limberis, M.P. et al. “Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza,” Sci Transl Med 5: 187ra72, May 29, 2013. [cited by applicant]
Lincoln, G.A. et al. “Blockade of Episodic Secretion of Luteinizing Hormone in the Ram by the Administration of Antibodies to Luteinizing Hormone Releasing Hormone,” Biol Reprod 21:1239-1245, 1979. [cited by applicant]
Lishko, P.V. et al. “The Control of Male Fertility by Spermatozoan Ion Channels,” Annual review of physiology 74: 453-475, 2012. [cited by applicant]
Liu et al., “Immune tolerance after delivery of dying cells to dendritic cells in situ,” J. Exp. Med., vol. 196, No. 8, pp. 1091-1097, 2002. [cited by applicant]
Lloyd, M.L. et al. “Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovims expressing mouse zona pellucida 3,” Biol Reprod 68, 2024-2032, 2003. [cited by applicant]
Locke. S.L. et al. “Effectiveness of Spayvac® for Reducing White-tailed Deer Fertility,” Journal of wildlife diseases 43: 726-730, 2007. [cited by applicant]
Loeffler and Behr “Gene transfer into primary and established manunalian cell lines with lipopolyamine-coated DNA,” Meth Enzymol 217: 599-618, 1993. [cited by applicant]
Ishino, T. et al. “Engineering a Monomeric Fe Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics,” J Biol Chem. 288: 16529-37, Apr. 24, 2013. [cited by applicant]
Lucas et al., “Phosphatidylserine binding is essential for plasma membrane recruitment and signaling function of 3-phosphoinositide-dependent kinase-1,” J. Biol. Chem., vol. 286, pp. 41265-41272, 2011. [cited by applicant]
Lucas, X. “Clinical use of deslorelin (GnRH agonist) in companion animals: a review,” Reproduction in Domestic Animals 49 Suppl 4, 64-71, 2014. [cited by applicant]
Luo et al., “ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms,” Proc. Natl. Acad. Sci. USA., vol. 105, pp. 14527-14532, 2008. [cited by applicant]
Macdonald, L.E. et al. “Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes,” Proc Natl Acad Sci US A 111, 5147-5152, 2014. [cited by applicant]
Mackenzie, S.M. et al. “Immunocontraceptive effects on female rabbits infected with recombinant myxoma virus expressing rabbit ZP2 or ZP3,” Biol Reprod 74, 511-521, 2006. [cited by applicant]
Magnusson, Kalle et al., Magnusson, K. et al. Demasculinization of the Anopheles gambiae X chromosome. BMC Evol. Biol. 12, 69 (2012)., Aug. 19, 2024. [cited by applicant]
Majowicz et al. “Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated vims 1 vector-mediated gene delivery,” Journal of Gene medicine. 15: 219-232, Jul. 16, 2013. [cited by applicant]
Majumdar, R. et al. “Docking and free energy simulations to predict conformational domains involved in Hcg-LH receptor interactions using recombinant antibodies,” Proteins 79: 3108-3122, 2011. [cited by applicant]
Marshall, J.M. et al., Samele: a killer-male, rescue-female system for suppression and replacement of insect disease vector populations, Genetics, vol. 187 No. 2, pp. 535-551; 2011. [cited by applicant]
Mastrangeli et al. “Diversity of airway epithelial cell targets for in vivo recombinant adenovims-mediated gene transfer,” J Clinical Invest 91: 225-234, 1993. [cited by applicant]
Matzuk, M.M. et al. “Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction,” J Biol Chem 264, 2409-2414, 1989. [cited by applicant]
McCormack, J.T. et al. “The Effect of Luteinizing Hormone Releasing Hormone (LHRH) Antiserum Administrationon Gonadotropin Secretion in the Rhesus Monkey,” Endocrinology 100: 663-667, 1977. [cited by applicant]
McGaha et al., “Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen,” Blood, vol. 117, No. 20, pp. 5403-5412, 2011. [cited by applicant]
McLaughlin, E.A. et al. “Cloning and sequence analysis of rat fertilin alpha and beta-developmental expression, processing and immunolocalization,” Molecular human reproduction 3: 801-809, 1997. [cited by applicant]
McLaughlin, E.A. et al. “Is there a role for immunocontraception?,” Molecular and cellular endocrinology 335: 78-88, 2011. [cited by applicant]
Meloen et al., “Efficient immunocastration of male piglets by immunoneutralization of GnRH using a new GnRH-like peptide,” Vaccine 12:741-746, 1994. [cited by applicant]
Midgley Jr. A.R., et al. “Nonclassical secretory dynamics ofLH revealed by hypothalamuseal portal sampling of sheep,” Endocrine 6: 133-143, 1997. [cited by applicant]
Miller et al. “Use of retroviral vectors for gene transfer and expression,” Meth Enzymol 217: 581-599, 1993. [cited by applicant]
Miller et al., “The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells,” J. Exp. Med., vol. 149, pp. 758-773, 1979. [cited by applicant]
Miller, A.O., “Retrovirus Packaging Cells,” Human Gene Therapy, vol. 1, pp. 5-14, 1990. [cited by applicant]
Miller, L.A. et al. “The Single-Shot GnRH Immunocontraceptive Vaccine (GonaCon™) in White-Tailed Deer: Comparison of Several GnRH Preparations,” Am J Reprod Immunol 60: 214-223, 2008. [cited by applicant]
Miller, L.A. et al. “Twenty years of immunocontraceptive research: lessons learned,” Journal of Zoo and Wildlife Medicine 44, S84-96, Dec. 2013. [cited by applicant]
Mingozzi, F. “Immune responses to AAV vectors: overcoming barriers to successful gene therapy,” Blood 122, 23-36, Jul. 4, 2013. [cited by applicant]
Mingozzi, F. et al. “Overcoming preexisting humoral immunity to AAVusing capsid decoys,” Sci Transl Med 5, 194ral92, Jul. 17, 2013. [cited by applicant]
Miyake et al., “Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens”, J. Clin. Invest., vol. 117, pp. 2268-2278, 2007. [cited by applicant]
Miyanishi et al., “Identification of Tim4 as a phosphatidylserine receptor,” Nature, vol. 450, pp. 435-439, 2007. [cited by applicant]
Morizono et al., “The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Ax1 to mediate viral entry,” Cell Host Microbe, vol. 9, pp. 286-298, 2011. [cited by applicant]
Morrison et al. “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains,” Proc Natl Acad Sci 81(21): 6851-6855, 1984. [cited by applicant]
Morton et al., “Marcks-ED peptide as a curvature and lipid sensor,” ACS Chemical Biology, vol. 8, pp. 218-225, 2013. [cited by applicant]
Munks, M.W. “Progress in Development of Immunocontraceptive Vaccines for Permanent Non-surgical Sterilization of Cats and Dogs,” Reproduction in Domestic Animals 47 (Suppl 4): 223-227, 2012. [cited by applicant]
Munoz et al., Theriogenology, (69): 1159-1164, 2008. [cited by applicant]
Murphy, A.J. et al. “Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice,” Proc Natl Acad Sci US A 111, 5153-5158, 2014. [cited by applicant]
Muzyczka “Use of adeno-associated virus as a general transduction vector for mammalian cells,” Curr Topics in Microbial Immunol 158: 97, 1992. [cited by applicant]
Nafissi, N. et al. “Construction and Characterization of an in-vivo Linear Covalently Closed DNA Vector Production System,” Microbial cell factories 11: 154, 2012. [cited by applicant]
Nagata et al., “Autoimmunity and the clearance of dead cells,” Cell, vol. 140, pp. 619-630, 2010. [cited by applicant]
Nagata et al., Sensing and clearance of apoptotic cells, Current Opinion in Immunology, vol. 68, pp. 1-8, 2021. [cited by applicant]
Nakahashi-Oda et al., “Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor,” Biochem Biophys Res Commun., vol. 417, pp. 646-650, 2012. [cited by applicant]
Nakai et al., “Isolation of a [cited by applicant]
Nathwani, A.C. et al. “Adenovims-Associated Vims Vector-Mediated Gene Transfer in Hemophilia B,” The New England journal of medicine 365: 2357-2365, 2011. [cited by applicant]
Naz et al. “Antibodies to sperm-specific human FA-1 inhibit in vitro fertilization in rhesus monkeys: development of a simian model for testing of anti-FA-1 contraceptive vaccine,” Journal of reproductive immunology 27:… [cited by applicant]
Naz et al. “Passive Immunization for Immunocontraception: Lessons Learned from Infections Diseases,” Frontiers in Bioscience 9:2457-2465, 2004. [cited by applicant]
Naz, “Contraceptive Vaccines”, Drugs, 65 (5):593-603 (2005). [cited by applicant]
Naz, “Recent advances in contraceptive vaccine development: a mini-review,” Human Reproduction, 20 (12):3271-3283 (2005). [cited by applicant]
Naz, R.K. “Recent progress toward development of vaccines against conception,” Expert Review of Vaccines 13, 145-154, 2014. [cited by applicant]
Nechansky, A. J. Pharm. Biomed. Anal. 2009;51 :252-254. [cited by applicant]
Neuberger et al. “Recombinant antibodies possessing novel effector functions,” Nature 312: 604-608, 1984. [cited by applicant]
Neves et al., “Imaging cell death. Journal of nuclear medicine: official publication,” Society of Nuclear Medicine, vol. 55, pp. 1-4, 2014. [cited by applicant]
Niemann, Transgenic Research, 7: 73-75 (1998). [cited by applicant]
Nimmerjahn, F. “Fcgamma receptors as regulators of immune responses,” Nature Rev Immunology 8, 34-47, 2008. [cited by applicant]
O'Rand, M. G. “Reversible Immunocontraception in Male Monkeys Immunized with Eppin,” Science 306: 1189-1190,2004. [cited by applicant]
Oberhofer et al., “Split versions of Cleave and Rescue selfish genetic elements for measured self limiting gene drive,” BA.PLoS Genet., Feb. 18, 2021; 17(2):e1009385. doi: 10.1371/journal.pqen.1009385. [cited by applicant]
Ogura et al. “Implantation of Genetically Manipulated Fibroblasts into Mice as Antitumor a-Interferon Therapy,” Cancer Research 50: 5102-5106, 1990. [cited by applicant]
Ohlsson et al., BMC Gastroenterology, 10: 48, 2010. [cited by applicant]
Oi, V.T. et al. “Correlation between segmental flexibility and effector function of antibodies,” Nature 307, 136-140, 1984. [cited by applicant]
Pai, M. et al. “Immunocontraception in Eastern Gray Squirrels ( [cited by applicant]
Paidassi et al., “C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition,” J. Immunol., vol. 180, pp. 2329-2338, 2008. [cited by applicant]
Pandey et al., “The forgotten tale of immunoglobulin allotypes in cancer risk and treatment,” Experimental hematology & oncology, vol. 2, p. 6, 2013. [cited by applicant]
Paris et al., Theriogenology, 74: 516-524, 2010. [cited by applicant]
Park et al., “BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module,” Nature, vol. 450, pp. 430-434, 2007. [cited by applicant]
Park et al., “Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance,” Mol. Cell Biol., vol. 28, pp. 5288-5298, 2008a. [cited by applicant]
Park et al., “Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor,” Cell Death Differ, vol. 15, pp. 192-201, 2008a. [cited by applicant]
Pasadena-humane-society. http://www.pasadenahumane.org/site/PageServer?pagename=services_snip_faq; Original publication date unknown; Version printed on Mar. 22, 2016. [cited by applicant]
Pausch et al. “A Nonsense Mutation in TMEM95 Encoding a Nondescript Transmembrane Protein Causes Idiopathic Male Subfertility in Cattle,” PLoS Genet. 10(1):el004044, 2014. [cited by applicant]
Pickard, A.R. and Holt, W.V. “Contraception in wildlife,” The journal of family planning and reproductive health care/ Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gvnaecologis… [cited by applicant]
Pittelkow and Scott “New Techniques for the In Vitro Culture of Human Skin Keratinocytes and Perspectives on Their Use for Grafting of Patients With Extensive Bums,” Mayo Clinic Proc 61: 771, 1986. [cited by applicant]
Poulsen et al., Journal ofImmunology, 187: 4229-4235, 2011. [cited by applicant]
Powers, J.G. et al. “Effects of Gonadotropin-Releasing Hormone Immunization on Reproductive Function and Behavior in Captive Female Rocky Mountain Elk ( [cited by applicant]
Presta, L.G. “Engineering of therapeutic antibodies to minimize immunogenicity and optimize function,” Advanced Drug Delivery Reviews 58: 640-656, 2006. [cited by applicant]
Price, E.O. et al. “Aggressive behavior is reduced in bulls actively immunized against gonadotropin-releasing hormone,” Journal of animal science 81: 411-415, 2003. [cited by applicant]
Primakoff, P. et al. “Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20,” Nature 335: 543-546, 1988. [cited by applicant]
Purohit et al., “Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex,” J. Biol. Chem., vol. 280, pp. 17593-17600, 2005. [cited by applicant]
Qi et al., “Differential membrane interactions of saposins A and C: implications for the functional specificity,” J. Biol. Chem., vol. 276, pp. 27010-27017, 2001. [cited by applicant]
Qiu et al., “Annexin V-Trail fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy,” Scientific reports, vol. 3, p. 3565, 2013. [cited by applicant]
Ramani et al., “Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A,” Journal of pharmaceutical sciences, vol. 97, pp. 1386-1398, 200… [cited by applicant]
Rankin, T.L. et al. “Human ZP3 restores fertility in Zp3 null mice without affecting order-specific sperm binding,” Development 125 : 2415-2424, 1998. [cited by applicant]
Ravishankar et al., “Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance,” Proc. Natl. Acad. Sci. USA, vol. 111, pp. 4215-4220, 2014. [cited by applicant]
Ravishankar et al., “O death where is thy sting? Immunologic tolerance to apoptotic self,” Cell Mol. Life Sci., vol. 70, pp. 3571-3589, 2013. [cited by applicant]
Reichmann et al., “Reshaping human antibodies for therapy,” Nature 332:323-327, 1988. [cited by applicant]
Reubel, G.H. et al. “Experimental inoculation of European red foxes with recombinant vaccinia vims expressing zona pellucida C proteins,” Vaccine 23, 4417-4426, 2005. [cited by applicant]
Rheinwald “Serial cultivation of normal human epidermal keratinocytes,” Meth Cell Bio 2IA: 229-254, 1980. [cited by applicant]
Robbins, S.C. et al. “Assessment of the immunological and biological efficacy of two different doses of a recombinant GnRH vaccine in domestic male and female cats ( [cited by applicant]
Roberts, K.P. et al. “Inhibition of Capacitation-Associated Tyrosine Phosphorylation Signaling in Rat Sperm by Epididymal Protein Crisp-I,” Biol Reprod 69: 572-581, 2003. [cited by applicant]
Robertson, I.S. et al. The Veterinary record 105: 556-557, 1979. [cited by applicant]
Robertson, I.S. et al. The Veterinary record 108: 381-382, 1981. [cited by applicant]
Robertson, I.S. et al. The Veterinary record 111: 529-531, 1982. [cited by applicant]
Rodriguez-Fernandez et al., Phosphatidylserine-liposomes Promote Tolerogenic Features on Dendritic cells in human Type 1 Diabetes by apoptotic Mimicry, Frontiers in Immunology vol. 9, Article 253, 17 pages, 2018. [cited by applicant]
Ronald, J.A. et al. “Development and Validation of Non-Integrative, Self-Limited, and Replicating Minicircles for Safe Reporter Gene Imaging of Cell-Based Therapies,” PLoS One e73138. doi: 10.1 371/journal.pone.0073138,… [cited by applicant]
Rosenbaum et al., “Identification of novel binding partners (annexins) for the cell death signal phosphatidylserine and definition of their recognition motif,” J. Biol. Chem., vol. 286, pp. 5708-5716, 2011. [cited by applicant]
Rosenberg, J.B et al. “AAVrh. 10-Mediated Expression of an Anti-Cocaine Antibody Mediates Persistent Passive Immunization That Suppresses Cocaine-Induced Behavior,” Hum Gene Ther 23: 451-459, 2012. [cited by applicant]
Rosenfeld et al. “Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo,” Science 252: 431-434, 1991. [cited by applicant]
Rosenfeld et al. “In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium,” Cell 68: 143-155, 1992. [cited by applicant]
Rudinger, “Characteristics of the amino acids as components of a peptide hormone sequence” Peptide Hormones, Parsons, (ed.), 1976 University Park Press, Baltimore, MD, pp. 1-7. [cited by applicant]
Rysavy, N.M et al., Beyond apoptosis: the mechanism and function of phosphatidylserine asymmetry in the membrane of activating mast cells. Bioarchitecture 4, pp. 127-137, (2014). [cited by applicant]
Saint Louis Zoo. http://www.stlzoo.org/animals/scienceresearch/contraceptioncenter/contraceptiomecommendatio/contraceptionmethods/; Original publication date unknown; Version printed on Mar. 22, 2016. [cited by applicant]
Salmons et al. “Targeting ofRetroviral Vectors for Gene Therapy,” Human Gene Therapy 4: 129-141, 1993. [cited by applicant]
Samoylov, A. et al. Zuchthygiene 47 (Suppl 6):406-411, 2012. [cited by applicant]
Samuel, A.S. et al. “Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development,” Hum Reprod 23, 1324-1337, 2008. [cited by applicant]
Samulski, R.J. et al. “AAV-mediated gene therapy for research and therapeutic purposes,” Annu. Rev. Virol. 1, 427-451, 2014. [cited by applicant]
Santiago et al., “TIM-4 structures identify a Metal Ion-dependent Ligand Binding Site where phosphatidylserine binds,” Immunity, vol. 27, pp. 941-951, 2007. [cited by applicant]
Santodonato, et al. “Cure of Mice with Established Metastatic Friend Leukemia Cell Tumors by a Combined Therapy with Tumor Cells Expressing Both Interferon-al and Herpes Simplex Thymidine Kinase Followed by Ganciclovir,… [cited by applicant]
Santodonato, et al. “Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-a and HSVtk: perspectives for the generation of cancer vaccines,” Gene Therapy… [cited by applicant]
Saunders, A. et al. “Novel recombinant adeno-associated viruses for Cre activated and inactivated transgene expression in neurons,” Frontiers in neural circuits 6: 47, 2012. [cited by applicant]
Sawai, H. et al. “Direct Production of the Fab Fragment Derived From the Sperm Immobilizing Antibody Using Polymerase Chain Reaction and cDNA Expression Vectors,” Am J Reprod immunology 34: 26-34, 1995. [cited by applicant]
Schakowski, F. et al. “Minimal Size Midge Vectors Improve Transgene Expression In Vivo,” In Vivo 21: 17-23, 2007. [cited by applicant]
Schneider, F. et al. “Gonadotropin-releasing hormone (GnRH) and its natural analogues: A review,” Theriogenology 66: 691-709, 2006. [cited by applicant]
Schnepp, B.C. et al. “Vector-mediated antibody gene transfer for infectious diseases,” Adv Exp Med Biol 848, 149-167, 2015. [cited by applicant]
Schulz, M.H. et al. “Oases: robust de novo TNA-seq assembly across the dynamic range of expression levels,” Bioinformatics 28, 1086-92, 2012. [cited by applicant]
Schwartz et al. “Clinical Evaluation of Live, Oral Types 1, 2, and 5 Adenovims Vaccines,” Am Rev RespirDis 109: 233-238, 1974. [cited by applicant]
Schweigert et al., “Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by a Disintegrin and Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine,” Biochim Biophys Acta, vol. 1843, pp. 275-28… [cited by applicant]
Segawa et al., An Apoptotic ‘Eat Me’ Signal: Phosphatidylserine Exposure. Trends Cell Biol, vol. 25, pp. 639-650, 2015. [cited by applicant]
Sen, D. “Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering,” Journal of Biomedical Science 21, 103, 2014. [cited by applicant]
Shao et al., “Crystal structure of lactadherin C2 domain at 1.7A resolution with mutational and computational analyses of its membrane-binding motif,” J. Biol. Chem. vol. 283, pp. 7230-7241, 2008. [cited by applicant]
Shore, N.D. “Experience with degarelix in the treatment of prostate cancer,” Therapeutic Advances in Urology 5, 11-24, Jan. 16, 2013. [cited by applicant]
Short, R.V. et al. “Influence of passive immunization against GnRH on pregnancy and parturition in the tammar wallaby, Macropus eugenii,” J Reprod Fertil 75: 567-575, 1985. [cited by applicant]
Silversides, D.W. et al. “Monoclonal antibodies against LHRH: development and immunoactivity in vivo and in vitro,” Journal of reproductive immunology 7: 171-184, 1985. [cited by applicant]
Simhadri et al., “Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells,” Blood, vol. 119, pp. 2799-2809, 2012. [cited by applicant]
Simms, M.S. et al. “Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer,” British Journal of Cancer 83, 443-446, 2000. [cited by applicant]
Singh, M. et al. “Regain of Fertility and Normality of Progeny Born During Below Protective Threshold Antibody Titers in Women Immunized With the HSD-hCG Vaccine,” Am J Reprod Immunology 39: 395-398, 1998. [cited by applicant]
Singleton et al., Title Page of Dictionary of Microbiology and Molecular Biology, J. Wiley & Sons, New York, N. Y., 1994, Second Edition. [cited by applicant]
Skerra et al. “Assembly of a functional immunoglobulin Fv fragment in [cited by applicant]